A skin biopsy to detect a rare neurodegenerative disease
Peer-Reviewed Publication
This month, we’re spotlighting Parkinson’s disease research in recognition of Parkinson’s Awareness Month. Here, we’ll share the latest research on Parkinson’s disease, how scientists are working to better understand its causes and progression, advances in treatment and care, and more.
Updates every hour. Last Updated: 9-May-2026 21:16 ET (10-May-2026 01:16 GMT/UTC)
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis are marked by the buildup of misfolded proteins that slowly destroy brain cells, yet treatments that address this root cause are still lacking. Interestingly, researchers provide a comprehensive review of the role of heat shock protein 70 (Hsp70) molecular chaperones in several neurodegenerative diseases. Notably, Hsp70 exert neuroprotective effects and mitigate the occurrence of pathological protein aggregates.
Parkinson’s disease is more common among individuals with a higher socioeconomic status and in the northern provinces of the Netherlands. In the southern provinces, Parkinson’s occurs less frequently. Men are at greater risk than women, and the risk increases with age, peaking between 75 and 85 years. These findings come from a large-scale study by researchers at Utrecht University and Radboudumc on the number of new patients and the distribution of Parkinson’s disease in the Netherlands between 2017 and 2022.
Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve significant immune dysfunction within and outside the central nervous system (CNS). A new review by Professor Qiang Liu's team at Tianjin Medical University General Hospital synthesizes evidence that dynamic interactions between brain-resident and peripheral immune cells are crucial in diseases like Parkinson's disease (PD), offering fresh perspectives for developing treatments that can modify disease progression.
A new study from UCLA Health has found that long-term residential exposure to the pesticide chlorpyrifos is associated with more than a 2.5-fold increased risk of developing Parkinson's disease. The research, published in the journal Molecular Neurodegeneration, combines human population data with laboratory experiments showing how the pesticide damages dopamine-producing brain cells, providing biological evidence for the link.
As people age, the brain undergoes multiple changes, increasing the vulnerability to neurological diseases. Early detection of neurological diseases is critical for effective treatment. In a recent study, researchers from China demonstrated that machine learning algorithms integrating imaging, genetic, and clinical data can significantly improve diagnostic accuracy and prediction, enabling timely interventions and better patient outcomes. This approach may transform clinical practice by improving precision, speed, and interpretability in assessing complex brain disorders.